Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 18 min ago
PreprintCC BYbioRxiv

Sensitivity of Pulmonary 4D Flow MRI Biomarkers to Controlled Spatial and Temporal Degradation in a CFD Benchmark

  1. 1CIC biomaGUNE, BRTA, San Sebastian, Spain; Universidad del Pais Vasco, Leioa, Spain

Abstract

Purpose: To quantify, in a computational fluid dynamics (CFD) benchmark, how spatial degradation, temporal acquisition and noise change the error of plane-based pulmonary-artery flow endpoints. Methods: Twenty-two historical, non-converged CFD simulations (11 geometry families) were voxelised at 2 mm with 80 frames per cycle. Simulations with numerical divergence were excluded, leaving 13 (7 families). Fields were degraded to 4 and 8 mm and with noise, plane waveforms were sampled at 20 phases with one-interval averaging, and errors were computed against the noise-free reference waveform on 66 geometric planes. Family-mean paired differences are reported with t-based 95% confidence intervals under an analysis plan fixed in advance. Results: Spatial degradation from 2 to 4 mm increased full-waveform nRMSE by 0.0032 [0.0021, 0.0043], in 7 of 7 families; cycle-mean flow bias accounted for 23% of the squared error, against 60% at 8 mm. With SNR scaled to voxel volume, the increase was not resolved (0.0002 [-0.0012, 0.0015]). Twenty-phase acquisition increased PI error (0.0223 [0.0214, 0.0233]) and diastolic-trough timing error (0.63 [0.52, 0.74] frames) more than spatial degradation, and its point estimates for these endpoints were larger with every recovery method; the nRMSE ordering and peak timing depended on the recovery method. The implementation of the downsampling operator mattered: an alternative, corner-aligned implementation of the same 4 mm degradation gave a larger spatial effect (nRMSE difference 0.0010 [0.0002, 0.0017]). Conclusion: In this benchmark, a 2 to 4 mm degradation produced a small, consistent, mostly shape-related nRMSE increase that depended on the noise model, whereas 20-phase acquisition changed PI error and trough timing more. The results describe benchmark behaviour, not clinical acquisition requirements.

Related

  1. Biomarker-Aware Super-Resolution for 4D Flow MRI in a Synthetic Pulmonary-Artery Benchmark
    A. Zubillaga-Unsain, A. Lluveras-Sires, C. Caballero-Gaudes +1
    bioRxivPreprintCC BYFull textSystems & synthetic biologybioRxiv
  2. Effect of different forms of upper limb muscle training on dyspnea in chronic obstructive pulmonary disease: a randomised controlled trial
    Marc Beaumont, Loic Péran, Anne Cécile Berriet +3
    Annals of Physical and Rehabilitation MedicinePeer-reviewedLicence not stated2 citedGeneral biologyHAL
  3. Vision Transformers versus convolutional neural networks for fine-grained orchid genus identification in a species-rich, data-poor flora: a controlled benchmark on the Orchidaceae of New Guinea
    Reza Saputra, Diah Harnoni Apriyanti, André Schuiteman +4
    arXivPreprintCC BY-NC-ND 4.0Full textBioinformatics & computational biologyarXiv
  4. Plasma CXCL13 and fibrosis biomarkers in COVID-19 compared with idiopathic pulmonary fibrosis
    Nicolas Gendron, Carla Rial, Clément Massonnaud +114
    Scientific ReportsPeer-reviewedCC BY 4.0Full textGeneral biologyInfectious diseaseHAL
  5. Altered GABAB receptor sensitivity in heavy drinkers indexed using a TMS-based biomarker: a randomized controlled experimental medicine trial
    Chiara Montemitro, Daphne Donahue, Andrea Costumati +7
    Translational PsychiatryPeer-reviewedCC BY 4.0Full textNeuroscienceCrossrefDOAJ
BibTeX
@misc{zubillagaunsain2026sensitivity,
  title = {{Sensitivity of Pulmonary 4D Flow MRI Biomarkers to Controlled Spatial and Temporal Degradation in a CFD Benchmark}},
  author = {A. Zubillaga-Unsain and C. Caballero-Gaudes and J. Ruiz-Cabello},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.30.755784},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.30.755784v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Sensitivity of Pulmonary 4D Flow MRI Biomarkers to Controlled Spatial and Temporal Degradation in a CFD Benchmark
AU  - A. Zubillaga-Unsain
AU  - C. Caballero-Gaudes
AU  - J. Ruiz-Cabello
PY  - 2026
DA  - 2026/09/30
PB  - bioRxiv
DO  - 10.64898/2026.09.30.755784
UR  - https://www.biorxiv.org/content/10.64898/2026.09.30.755784v1
AB  - Purpose: To quantify, in a computational fluid dynamics (CFD) benchmark, how spatial degradation, temporal acquisition and noise change the error of plane-based pulmonary-artery flow endpoints. Methods: Twenty-two historical, non-converged CFD simulations (11 geometry families) were voxelised at 2 mm with 80 frames per cycle. Simulations with numerical divergence were excluded, leaving 13 (7 families). Fields were degraded to 4 and 8 mm and with noise, plane waveforms were sampled at 20 phases with one-interval averaging, and errors were computed against the noise-free reference waveform on 66 geometric planes. Family-mean paired differences are reported with t-based 95% confidence intervals under an analysis plan fixed in advance. Results: Spatial degradation from 2 to 4 mm increased full-waveform nRMSE by 0.0032 [0.0021, 0.0043], in 7 of 7 families; cycle-mean flow bias accounted for 23% of the squared error, against 60% at 8 mm. With SNR scaled to voxel volume, the increase was not resolved (0.0002 [-0.0012, 0.0015]). Twenty-phase acquisition increased PI error (0.0223 [0.0214, 0.0233]) and diastolic-trough timing error (0.63 [0.52, 0.74] frames) more than spatial degradation, and its point estimates for these endpoints were larger with every recovery method; the nRMSE ordering and peak timing depended on the recovery method. The implementation of the downsampling operator mattered: an alternative, corner-aligned implementation of the same 4 mm degradation gave a larger spatial effect (nRMSE difference 0.0010 [0.0002, 0.0017]). Conclusion: In this benchmark, a 2 to 4 mm degradation produced a small, consistent, mostly shape-related nRMSE increase that depended on the noise model, whereas 20-phase acquisition changed PI error and trough timing more. The results describe benchmark behaviour, not clinical acquisition requirements.
ER  -